Form 4: Forte Biosciences CFO Antony A. Riley Reports Stock Transactions
SEC Form 4 Filing
Forte Biosciences CFO Antony A. Riley reports the vesting and subsequent disposal of restricted stock units.
Summary
- On July 1, 2024, Antony A. Riley, CFO of Forte Biosciences, Inc., had 9,375 restricted stock units (RSUs) vest.
- These RSUs converted into common stock.
- Riley then disposed of 3,345 shares of common stock at a price of $0.546 per share to cover tax obligations.
- Following these transactions, Riley directly owns 200,504 shares of Forte Biosciences common stock and 93,750 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions, and doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in the CFO's stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/01/2023 | Beginning of quarterly vesting dates for restricted stock units. |
| 07/01/2024 | Date of restricted stock unit vesting and stock disposal. |
| 07/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.